908 Devices Inc.

Industrials
Industrial Machinery/Components
www.908devices.com

Moat Score

Market Cap $77.44M
PE -1
Debt $NaN
Cash $45.20M
EV $NaN
FCF -$30.68M

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$60.19M
EBIT	-$60.40M
ROE	-46%
ROA	-34%
FCF	-$30.68M
Equity	$131.04M
Growth Stability	1
PE	-1.29
PB	0.59
P/FCF	-2.52
P/S	1.4
Price/Cash	0.58
Net Margins	-129%
Gross Margins	51%
Op. Margins	-109%
Sales Growth YoY	17%
Sales Growth QoQ	19%
Sales CAGR	19%
Equity CAGR	2%
Earnings Growth YoY	313%

Earnings Growth QoQ	133%
Sales CAGR 5Y	19%
Equity CAGR 5Y	2%
Earnings CAGR 3Y	7%
Sales CAGR 3Y	7%
Equity CAGR 3Y	-14%
Market Cap	$77.44M
Revenue	$55.16M
Assets	$178.28M
Cash	$45.20M
Shares Outstanding	33.82M
Moat Score	1%
Working Capital	83.21M
Current Ratio	4.24
Gross Profit	$28.03M
Shares Growth 3y	5%
Equity Growth QoQ	-16%
Equity Growth YoY	-23%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.

SEC Filings

Direct access to 908 Devices Inc. (MASS) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does 908 Devices Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of 908 Devices Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

908 Devices Inc. Discounted Cash Flow

Fully customizable DCF calculator online for 908 Devices Inc..

Years

Calculation mode

= -$307M

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	-$31M	-$31M	-$31M	-$31M	-$31M	-$31M	-$31M	-$31M	-$31M	-$31M	-$31M	-$307M
DCF		-$28M	-$25M	-$23M	-$21M	-$19M	-$17M	-$16M	-$14M	-$13M	-$12M	-$118M
Value	-$307M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2020	12/2021	12/2022	12/2023	TTM
Net Margins	-48%	-53%	-72%	-72%	-129%
ROA	-	-8%	-14%	-18%	-34%
ROE	-	-10%	-18%	-22%	-46%

Bad Net Margins (-129.28%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2020	12/2021	12/2022	12/2023	TTM
Debt over FCF	-	-0.5	-0.65	-	-
Debt over Equity	0.11	0.07	0.08	-	-
Growth Stability	-	-	-	-	1

Neutral Debt/FCF ratio (-)

Net Margins are at a level that is not too high nor too low. They are not a competitive advantage but they are not a competitive disadvantage either.

Neutral Debt/Equity ratio (-)

The company has a balance between equity and debt that is not too good nor too bad.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2020	12/2021	12/2022	12/2023	CAGR 5Y
Revenue YoY growth	-	57%	11%	7%	19%
Earnings YoY growth	-	72%	51%	8%	-
Equity YoY growth	-	54%	-11%	-13%	2%
FCF YoY growth	-	-823%	-23%	18%	-